SAN DIEGO, June 20, 2023 Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious. | June 20, 2023
Cidara Therapeutics to Present at Adenosine Pathway Targeted Cancer Immunotherapy Summit tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
hVIVO PLC on Monday said that Cidara Therapeutics Inc has seen positive results from an ongoing study testing CD388, a drug designed to treat seasonal flu.
hVIVO is a London-based specialist. | April 3, 2023
hVIVO touts positive test results from seasonal flu drug, CD388 lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.